Benzinga  Oct 2  Comment 
Esperion Therapeutics (NASDAQ: ESPR) shares reached a new 52-week high of $27.905 after the company announced positive top-line Phase 2b results for ETC-1002. Sagent Pharmaceuticals (NASDAQ: SGNT) shares touched a new 52-week high of $32.12...
SeekingAlpha  Aug 2  Comment 
Reis, Inc. (NASDAQ:REIS) Q2 2014 Earnings Conference Call July 31, 2014 11:00 AM ET Executives Lloyd Lynford – Chief Executive Officer Mark Cantaluppi – Vice President and Chief Financial Officer Analysts Kara Anderson...



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki